Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9520
Controlled Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
Activated
12-15-1995
Closed
10-01-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9500
A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia
Research Committee(s)
Leukemia
Activated
12-15-1995
Closed
04-01-1997
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
SWOG-9458
Evaluation of Ki-67, p53 and Angiogenesis in Patients Registered to SWOG-8710, Ancillary
Research Committee(s)
Genitourinary Cancer
Activated
11-15-1995
Closed
11-01-1998
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
SWOG-9316
Distribution of Retroperitoneal Metastases Post-Chemotherapy in Patients with Nonseminomatous Germ Cell Tumors, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
11-01-1995
Closed
10-15-1996
Closed
Phase
Accrual
90%
SWOG Clinical Trial Number
SWOG-9462 (NABTC-9404) (NCI T94-0034)
A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy
Research Committee(s)
Brain Cancer
Activated
07-28-1995
Closed
08-15-1997
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
SWOG-9400
Treatment of Adult Lymphoblastic Leukemia: A Phase II Trial of An Induction Regimen Including PEG-L-Asparaginase in Previously Untreated Patients, Followed By Allogeneic Bone Marrow Transplantation or Further Chemotherapy In First Complete Remission
Research Committee(s)
Leukemia
Activated
07-15-1995
Closed
05-01-2000
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9438
Total Body Irradiation, Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation Followed by Randomization to Therapy With Interleukin-2 Versus Observation for Patients With Non-Hodgkin's Lymphoma, A BMT Study, Phase III
Research Committee(s)
Lymphoma
Activated
05-15-1995
Closed
07-01-2004
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
SWOG-9346
Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
05-15-1995
Closed
09-01-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9413
Phase II Treatment with Etoposide (E), Leucovorin (L), 5-Fluorouracil (F) and Interferon Alpha 2b (I), (ELFI) + G-CSF for Locally Advanced or Recurrent Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-1995
Closed
03-15-1996
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-9432
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
SWOG-9436 (NABTC-9403) (NCI T94-0184)
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma
Research Committee(s)
Brain Cancer
Activated
04-18-1995
Closed
02-04-1998
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
SWOG-9239
Phase II Trial of Sequential Modification of Immunosuppression, Interferon Alpha, and ProMACE-CytaBOM for Treatment of Post-Organ Transplant Lymphoproliferation
Research Committee(s)
Lymphoma
Activated
04-15-1995
Closed
08-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9420
A Phase III Trial of Continuous Low-Dose Infusion versus Intermittent High-Dose Infusion of 5-Fluorouracil in Patients with Disseminated Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1995
Closed
05-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9416
Induction Chemoradiotherapy Followed by Surgical Resection, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors): A Phase II Trial
Research Committee(s)
Lung Cancer
Activated
04-15-1995
Closed
08-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9501
A Phase II Trial of Fludarabine and Mitoxantrone (FN) for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
04-01-1995
Closed
02-15-1996
Closed
Phase
SWOG Clinical Trial Number
SWOG-9419
Tumor Tissue Biopsy for Thymidylate Synthase Expression in Patients with Colorectal Cancer, Ancillary
Research Committee(s)
Gastrointestinal Cancer
Activated
03-15-1995
Closed
08-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9426
A Phase II Trial of Antiandrogen Withdrawal In Patients with Progressive Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
03-15-1995
Closed
06-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9324
Phase II Trial of Vinorelbine Tartrate (Navelbine®) for Patients with Relapsed Ovarian Cancer
Research Committee(s)
Gynecologic Cancer
Activated
03-15-1995
Closed
07-01-1997
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
SWOG-9249
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
SWOG-9445
Prognostic Factor Panel to Predict Preferred Therapy for Node Positive Postmenopausal Breast Cancer Patients (CAF vs. Tamoxifen) (a Companion Protocol to SWOG-8814 [INT-0100, CALGB-9194, EST-4188, NCCTG-883051, NCIC-MA.9])
Research Committee(s)
Breast Cancer
Activated
02-01-1995
Closed
10-01-1998